Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea. ; Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Korean J Anesthesiol. 2013 Mar;64(3):229-33. doi: 10.4097/kjae.2013.64.3.229. Epub 2013 Mar 19.
Shivering is a frequent event during spinal anesthesia and meperidine is a well-known effective drug for prevention and treatment of shivering. Nefopam is a non-opiate analgesic and also known to have an anti-shivering effect. We compared nefopam with meperidine for efficacy of prevention of shivering during spinal anesthesia.
Sixty five patients, American Society of Anesthesiologists physical status I or II, aged 20-65 years, scheduled for elective orthopedic surgery under spinal anesthesia were investigated. Patients were randomly divided into two groups, meperidine (Group M, n = 33) and nefopam (Group N, n = 32) groups. Group M and N received meperidine 0.4 mg/kg or nefopam 0.15 mg/kg, respectively, in 100 ml of isotonic saline intravenously. All drugs were infused for 15 minutes by a blinded investigator before spinal anesthesia. Blood pressures, heart rates, body temperatures and side effects were checked before and at 15, 30, and 60 minutes after spinal anesthesia.
The incidences and scores of shivering were similar between the two groups. The mean arterial pressures in Group N were maintained higher than in Group M at 15, 30, and 60 minutes after spinal anesthesia. The injection pain was checked in Group N only and its incidence was 15.6%.
We conclude that nefopam can be a good substitute for meperidine for prevention of shivering during spinal anesthesia with more stable hemodynamics, if injection pain is effectively controlled.
在脊髓麻醉期间,颤抖是一种常见的事件,哌替啶是预防和治疗颤抖的知名有效药物。奈福泮是一种非阿片类镇痛药,也具有抗颤抖作用。我们比较了奈福泮与哌替啶预防脊髓麻醉期间颤抖的效果。
65 名美国麻醉医师协会身体状况 I 或 II 级,年龄 20-65 岁,择期接受脊髓麻醉下骨科手术的患者进行了研究。患者随机分为两组,哌替啶(M 组,n = 33)和奈福泮(N 组,n = 32)组。M 组和 N 组分别给予 0.4 mg/kg 哌替啶或 0.15 mg/kg 奈福泮,在脊髓麻醉前 15 分钟内用 100ml 等渗生理盐水静脉输注。所有药物均由一位盲法研究者输注 15 分钟。在脊髓麻醉前、麻醉后 15、30 和 60 分钟检查血压、心率、体温和副作用。
两组的颤抖发生率和评分相似。脊髓麻醉后 15、30 和 60 分钟,N 组的平均动脉压均高于 M 组。仅在 N 组检查注射疼痛,其发生率为 15.6%。
我们的结论是,如果有效控制注射疼痛,奈福泮可以作为预防脊髓麻醉期间颤抖的哌替啶的良好替代品,具有更稳定的血液动力学。